Related Experiment Video
Updated: Jul 13, 2026
09:41
A Simple Critical-sized Femoral Defect Model in Mice
Published on: March 15, 2015
Type I diabetic bone phenotype is location but not gender dependent
Lindsay M Martin1, Laura R McCabe
1Department of Physiology, Biomedical Imaging Research Center, Michigan State University, 2201 Biomedical Physical Science Bldg, East Lansing, MI 48824, USA. marti643@msu.edu
Histochemistry and Cell Biology
|July 5, 2007
Summary
Type I diabetes causes bone loss in mice, regardless of gender or bone location. However, increased marrow fat accumulation due to diabetes is dependent on bone site.
Area of Science:
- Orthopedics and Endocrinology
- Bone Biology and Metabolism
Background:
- Bone is a dynamic tissue sensitive to various factors including location, type, and gender.
- Type I diabetes is known to cause bone loss and increase marrow fat, particularly in the tibia.
Purpose of the Study:
- To investigate the gender and location dependency of bone responses in Type I diabetes.
- To examine bone mineral density (BMD) and marrow adiposity in the femur, vertebrae, and calvaria of diabetic and control mice.
Main Methods:
- Streptozotocin-induced diabetes model in male and female BALB/c mice.
- Analysis of bone parameters (BMD) and marrow adiposity in femur, vertebrae, and calvaria.
- Comparison of diabetic mice with non-diabetic controls and assessment of serum leptin levels.
Main Results:
- Diabetes reduced BMD across all examined bone sites (femur, vertebrae, calvaria) in both genders.
- Increased marrow adiposity was observed in diabetic femurs and calvaria, but not vertebrae.
- Serum leptin levels were lower in diabetic mice, and unlike leptin-deficient mice, diabetic vertebrae showed bone loss.
Conclusions:
- Type I diabetes-induced bone loss in mice is not dependent on gender, bone location, or bone type.
- Increased marrow adiposity in Type I diabetes is site-specific.
- The distinct response in vertebrae suggests complex mechanisms beyond leptin deficiency in diabetic bone changes.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...